In this interview with Hearing Health Matters, Celia and Peter recount their successful strategic collaboration, marking its fifth anniversary, and their recent award for their innovative preclinical auditory services in…
CILcare is glad to announce that Marie Peytavy-Izard, Marketing & Business Development Director, and Susanna Malmström, Alliances Director, will be holding a booth at the 2022 edition of BioFIT. Taking…
LEXINGTON, Mass., USA, October 21st, 2022 — CILcare, a leading R&D services company dedicated to ear disorders, announced today that the company and its partner CBSET Inc., a not-for-profit translational research…
CILcare and its partner CBSET are proud to announce their nomination at the Hearing Technology Innovator Awards, which highlights their innovative auditory services that accelerate research and development of novel…
CILcare is glad to announce that its R&D team will be presenting its latest advances on preclinical hearing loss models at the 57th Inner Ear Biology workshop in Trieste, Italy,…
CILcare is pleased to announce that Marie-Pierre Pasdelou, Co-Founder & Chief Regulatory Officer, and Lise Byelyayeva, Business Developer, will be in Maastricht on September 18-21, 2022 to give presentations about…
Have you missed CILcare's presentation on chronic inflammatory diseases and hearing loss at Inner Ear Disorders Therapeutics Summit 2022? Mathieu SCHUE, PhD, CILcare’s Project Director in Drug Development and Translational…
We are pleased to announce that Camille Dejean, Research Engineer at CILcare and PhD student in collaboration with the Institut Pour l'Audition and Pasteur Institute, will be at the Federation…
We are pleased to announce that CILcare's Chief Scientific Officer, Sylvie Pucheu, PhD, will be at the Children Tumour Foundation's NF Conference in Philadelphia on June 19th to give a…
For the second year in a row, CILcare will be sponsoring this event dedicated to inner ear therapeutics development to further act towards better treatments and innovation for those suffering…
